PROCEDURE · Unmapped registry intervention
IBZM-SPECT (bolus and constant infusion paradigm)
Find medicine records ·
Find other trials using this name
Clinical trial
Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects
NCT00166322
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
Sponsors & collaborators
Ludwig-Maximilians - University of Munichlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00166322 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.